Agilent Feb 13, 2026 Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Endpoints News Feb 13, 2026 Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO
Endpoints News Feb 13, 2026 PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna
Agilent Feb 13, 2026 FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st
Agilent Feb 13, 2026 Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent Feb 13, 2026 Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider
10x Genomics Blog Feb 13, 2026 10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpass - GuruFocus
10x Genomics Blog Feb 12, 2026 Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
10x Genomics Blog Feb 12, 2026 Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics - Nasdaq
Thermo Fisher Feb 12, 2026 Thermo Fisher Scientific Inc. (TMO): Our Calculation of Intrinsic Value - The Acquirer's Multiple
BioPharma Dive Feb 12, 2026 Earnings roundup: Neurocrine slumps, Alnylam battles skeptics and Ascendis eyes a competitor